MedEquities Realty Trust Inc (MRT) Position Trimmed by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. cut its holdings in shares of MedEquities Realty Trust Inc (NYSE:MRT) by 2.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,238,820 shares of the financial services provider’s stock after selling 65,414 shares during the quarter. Goldman Sachs Group Inc. owned about 0.07% of MedEquities Realty Trust worth $25,120,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MRT. American Century Companies Inc. lifted its position in MedEquities Realty Trust by 22.3% during the fourth quarter. American Century Companies Inc. now owns 2,111,333 shares of the financial services provider’s stock worth $23,689,000 after buying an additional 385,125 shares during the period. Schwab Charles Investment Management Inc. lifted its position in MedEquities Realty Trust by 69.2% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 776,946 shares of the financial services provider’s stock worth $8,718,000 after buying an additional 317,829 shares during the period. Bank of New York Mellon Corp lifted its position in MedEquities Realty Trust by 192.4% during the fourth quarter. Bank of New York Mellon Corp now owns 343,285 shares of the financial services provider’s stock worth $3,851,000 after buying an additional 225,882 shares during the period. State Street Corp lifted its position in MedEquities Realty Trust by 41.7% during the second quarter. State Street Corp now owns 529,702 shares of the financial services provider’s stock worth $6,684,000 after buying an additional 155,934 shares during the period. Finally, Systematic Financial Management LP purchased a new position in MedEquities Realty Trust during the fourth quarter worth about $1,413,000. Hedge funds and other institutional investors own 92.76% of the company’s stock.

How to Become a New Pot Stock Millionaire

Several research firms recently weighed in on MRT. Zacks Investment Research downgraded MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. ValuEngine upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research report on Friday, December 1st. Cantor Fitzgerald reiterated a “buy” rating and set a $14.00 target price on shares of MedEquities Realty Trust in a research report on Wednesday, February 21st. B. Riley set a $13.00 price objective on MedEquities Realty Trust and gave the stock a “buy” rating in a report on Thursday, February 22nd. Finally, Citigroup cut their price objective on MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Thursday, March 1st. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $12.50.

MedEquities Realty Trust stock opened at $10.09 on Friday. The company has a market capitalization of $323.97, a PE ratio of 15.77 and a beta of 0.21. MedEquities Realty Trust Inc has a twelve month low of $9.67 and a twelve month high of $13.06.

MedEquities Realty Trust (NYSE:MRT) last released its quarterly earnings data on Wednesday, February 21st. The financial services provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.13). The firm had revenue of $16.23 million during the quarter, compared to analysts’ expectations of $16.31 million. MedEquities Realty Trust had a return on equity of 5.99% and a net margin of 34.96%. The business’s revenue for the quarter was up 13.8% compared to the same quarter last year. During the same quarter last year, the business earned ($0.06) earnings per share. analysts forecast that MedEquities Realty Trust Inc will post 1.21 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 5th. Stockholders of record on Monday, February 19th were issued a $0.21 dividend. The ex-dividend date was Thursday, February 15th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 8.33%. MedEquities Realty Trust’s dividend payout ratio (DPR) is 131.25%.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3298772/medequities-realty-trust-inc-mrt-position-trimmed-by-goldman-sachs-group-inc.html.

MedEquities Realty Trust Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Want to see what other hedge funds are holding MRT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MedEquities Realty Trust Inc (NYSE:MRT).

Institutional Ownership by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nitto Denko  Lowered to “Hold” at Zacks Investment Research
Nitto Denko Lowered to “Hold” at Zacks Investment Research
Navigant Consulting  Set to Announce Quarterly Earnings on Tuesday
Navigant Consulting Set to Announce Quarterly Earnings on Tuesday
Newfield Exploration  Set to Announce Earnings on Tuesday
Newfield Exploration Set to Announce Earnings on Tuesday
Homology Medicines  Now Covered by Bank of America
Homology Medicines Now Covered by Bank of America
$0.12 Earnings Per Share Expected for Finisar  This Quarter
$0.12 Earnings Per Share Expected for Finisar This Quarter
Kansas City Southern Railway  Given New $132.00 Price Target at Credit Suisse Group
Kansas City Southern Railway Given New $132.00 Price Target at Credit Suisse Group


© 2006-2018 Ticker Report. Google+.